Notably, large-scale analyses of neo-antigen-specific T cell reactivity have been carried out for melanoma patients, showing that only a small fraction of non-synonymous mutations in expressed genes leads to the formation of neo-antigen for which CD4+ and CD8+ T cell reactivity can be detected within tumor-infiltrating lymphocytes. Here, CD8A is linked to melanoma.